Related Experiment Video

Updated: Mar 10, 2026

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

6.2K

Development of bullous pemphigoid during nivolumab therapy

William Damsky1, Lauren Kole1, Mary M Tomayko1

  • 1Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

JAAD Case Reports
|December 17, 2016
PubMed
Abstract

No abstract available in PubMed .

Keywords:
BP, bullous pemphigoidBregs, B regulatory cellsCTLA-4, cytotoxic T-lymphocyte–associated protein 4IRAE, immune-related adverse eventsPD-1, programmed cell death protein 1PD-L1, programmed death ligand 1bullous pemphigoidnivolumabpembrolizumabprogrammed cell death protein 1programmed cell death protein 1 inhibitor

More Related Videos

Granulocyte-dependent Autoantibody-induced Skin Blistering12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

11.0K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.8K

Related Concept Videos